Dr. Campbell is a Board Certified Diplomate of the American Board of Toxicology. She has over 20 years of experience working in toxicological research, 20 years of applied analytical chemistry experience, 14 years of experience in pharmaceutical research (including both clinical and nonclinical), and 12 years of experience as a bench chemist. Her particular areas of interest include medical device and pharmaceutical nonclinical program design and implementation, investigative toxicology, risk assessment of extractable & leachable compounds from medical devices, and regulatory interactions.
Dr. Campbell received her Ph.D. in Pharmacology and Toxicology from the College of Pharmacy at the University of Utah. She then completed a Clinical Pharmacology Fellowship under the School of Medicine in the Department of Pediatrics, Division of Clinical Pharmacology and Clinical Trials Office at the University of Utah. Her fellowship research involved study design and IRB/IACUC protocol development for translational, preclinical, and clinical research. Most her research was undertaken in special populations and involved clinical toxicology, personalized medicine, pharmacogenomics, drug-drug interactions, pharmacokinetics/toxicokinetics, pharmacodynamics, pharmaceutical drug formulation, and clinical decision making studies. Several peer-reviewed scientific articles and conference papers resulted from this work. Dr. Campbell has also authored three book chapters. She has obtained vast knowledge of nonclinical GLP regulatory requirements and clinical GCP regulatory requirements for human subject research, healthcare compliance, and FDA bioassay analytical method development for investigational new drugs (INDs). Dr. Campbell is also currently eligible to sit for the American Board of Clinical Pharmacology exam.
Dr. Campbell’s experiences include dissertational research conducted at the Center for Human Toxicology which involved the development of a novel hair biomarker of toxic tobacco smoke exposure utilizing mass spectrometry method development and histopathology. During this time, she also obtained project funding and was the Principle Investigator of a National Children’s Study Innovative Research Grant which addressed toxic tobacco exposure in children. Previous to her graduate studies, she was an Analytical Chemist in industry for seven years. As an Analytical Chemist, she prepared and analyzed industrial hygiene and environmental samples for over 60 different analytes in various types of matrices for commercial clients as well as for contracts under EPA, NIOSH, OSHA, and DOD, among others.